Evidence map›Paper›PMID 32893926›Full record

ArticleJournal of veterinary internal medicine2020

The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs.

Susan M Jones, Ann Gaier, Hiroko Enomoto, Patricia Ishii, Rachel Pilla, Josh Price, Jan Suchodolski, Joerg M Steiner, Mark G Papich, Kristen Messenger and 1 more

Open access · goldAbstract readClinical Trial, Veterinary
In one paragraph

Article in Journal of veterinary internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Equine Gastric Ulcer Syndrome: An Update on Current Knowledge.Animals : an open access journal from MDPI · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Non-Steroidal Anti-Inflammatory Drugs and Associated Toxicities in Horses.Animals : an open access journal from MDPI · 2022
    Review
  15. Article
  16. Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2022
    Article
  17. Article
  18. Analysis of the gut microbiome in dogs and cats.Veterinary clinical pathology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Susan M JonesCollege of Veterinary Medicine, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Ann GaierCollege of Veterinary Medicine, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Hiroko EnomotoCollege of Veterinary Medicine, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Patricia IshiiDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Rachel PillaDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0001-7758-2609
Josh PriceOffice of Information and Technology, University of Tennessee, Knoxville, Tennessee, USA.
Jan SuchodolskiDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-2176-6932
Joerg M SteinerDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0003-3336-2086
Mark G PapichCollege of Veterinary Medicine, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.ORCID https://orcid.org/0000-0002-7591-7898
Kristen MessengerCollege of Veterinary Medicine, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
M Katherine TolbertDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0001-8725-9530
North Carolina State University · USTexas College · USUniversity of Tennessee at Knoxville · US

Funding

Interdisciplinary Biomedical Research Training ProgramT35OD011070 · OD · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Ronald Hak Long Li · 2012 to 2026
$1.1M
AVMF Research Grant for Pain Management in DogsNational Institutes of Health T-35 Interdisciplinary Biomedical Research Training ProgramNIH HHS T35 OD011070
6 · The paper itself

Abstract

backgroundProton pump inhibitors (eg, omeprazole) commonly are administered concurrently with nonsteroidal anti-inflammatory drugs (NSAIDs; eg, carprofen) as prophylaxis to decrease the risk of gastrointestinal (GI) injury. However, evidence to support this practice is weak, and it might exacerbate dysbiosis and inflammation. HYPOTHESIS/

objectivesTo evaluate the effect of carprofen alone or combined with omeprazole in dogs. We hypothesized that coadministration of omeprazole and carprofen would significantly increase GI permeability and dysbiosis index (DI) compared to no treatment or carprofen alone. ANIMALS: Six healthy adult colony beagle dogs.

methodsGastrointestinal permeability and inflammation were assessed by serum lipopolysaccharide (LPS) concentration, plasma iohexol concentration, fecal DI, and fecal calprotectin concentration in a prospective, 3-period design. In the first 7-day period, dogs received no intervention (baseline). During the 2nd period, dogs received 4 mg/kg of carprofen q24h PO for 7 days. In the 3rd period, dogs received 4 mg/kg of carprofen q24h and 1 mg/kg of omeprazole q12h PO for 7 days. Gastrointestinal permeability testing was performed at the end of each period. Data were analyzed using repeated measures mixed model analysis of variance with Tukey-Kramer post hoc tests (P < .05).

resultsSerum LPS and plasma iohexol concentrations did not differ between treatments. Fecal calprotectin concentrations differed between treatments (P = .03). The DI varied over time based on the treatment received (P = .03). Coadministration of omeprazole and carprofen significantly increased fecal calprotectin concentration and DI compared to baseline and carprofen alone. CONCLUSIONS AND CLINICAL IMPORTANCE: Omeprazole prophylaxis induces fecal dysbiosis and increases intestinal inflammatory markers when coadministered with carprofen to otherwise healthy dogs with no other risk factors for GI bleeding.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalDog DiseasesOmeprazoleAnimalsCarbazolesDogsFemaleInflammationMalePermeabilityProspective StudiesAnti-Inflammatory Agents, Non-SteroidalCarbazolescarprofenOmeprazolecaninedysbiosisnonsteroidal anti-inflammatory drugproton pump inhibitor

Identifiers

PMID32893926
PMCPMC7517840
OpenAlexW3084368090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.